MKKGY
Price
$25.04
Change
+$0.20 (+0.81%)
Updated
Sep 26 closing price
Capitalization
54.05B
46 days until earnings call
SUPN
Price
$47.03
Change
-$0.15 (-0.32%)
Updated
Sep 26 closing price
Capitalization
2.64B
44 days until earnings call
Interact to see
Advertisement

MKKGY vs SUPN

Header iconMKKGY vs SUPN Comparison
Open Charts MKKGY vs SUPNBanner chart's image
Merck KGaA
Price$25.04
Change+$0.20 (+0.81%)
Volume$197.58K
Capitalization54.05B
Supernus Pharmaceuticals
Price$47.03
Change-$0.15 (-0.32%)
Volume$594.77K
Capitalization2.64B
MKKGY vs SUPN Comparison Chart in %
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKKGY vs. SUPN commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a Hold and SUPN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (MKKGY: $25.04 vs. SUPN: $47.03)
Brand notoriety: MKKGY and SUPN are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MKKGY: 140% vs. SUPN: 71%
Market capitalization -- MKKGY: $54.05B vs. SUPN: $2.64B
MKKGY [@Pharmaceuticals: Generic] is valued at $54.05B. SUPN’s [@Pharmaceuticals: Generic] market capitalization is $2.64B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 0 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, SUPN is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 3 TA indicator(s) are bullish while SUPN’s TA Score has 3 bullish TA indicator(s).

  • MKKGY’s TA Score: 3 bullish, 5 bearish.
  • SUPN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than MKKGY.

Price Growth

MKKGY (@Pharmaceuticals: Generic) experienced а -1.57% price change this week, while SUPN (@Pharmaceuticals: Generic) price change was +2.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.18%. For the same industry, the average monthly price growth was +24.24%, and the average quarterly price growth was +67.33%.

Reported Earning Dates

MKKGY is expected to report earnings on Nov 13, 2025.

SUPN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.18% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKKGY($54B) has a higher market cap than SUPN($2.64B). SUPN has higher P/E ratio than MKKGY: SUPN (40.90) vs MKKGY (16.18). SUPN YTD gains are higher at: 30.061 vs. MKKGY (-10.976). MKKGY has higher annual earnings (EBITDA): 5.87B vs. SUPN (174M). MKKGY has more cash in the bank: 1.57B vs. SUPN (523M). SUPN has less debt than MKKGY: SUPN (31.8M) vs MKKGY (9.4B). MKKGY has higher revenues than SUPN: MKKGY (21.2B) vs SUPN (665M).
MKKGYSUPNMKKGY / SUPN
Capitalization54B2.64B2,048%
EBITDA5.87B174M3,374%
Gain YTD-10.97630.061-37%
P/E Ratio16.1840.9040%
Revenue21.2B665M3,188%
Total Cash1.57B523M301%
Total Debt9.4B31.8M29,566%
FUNDAMENTALS RATINGS
MKKGY vs SUPN: Fundamental Ratings
MKKGY
SUPN
OUTLOOK RATING
1..100
5029
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
10036
SMR RATING
1..100
7081
PRICE GROWTH RATING
1..100
7840
P/E GROWTH RATING
1..100
89100
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (23) in the null industry is somewhat better than the same rating for SUPN (78) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew somewhat faster than SUPN’s over the last 12 months.

SUPN's Profit vs Risk Rating (36) in the Pharmaceuticals Other industry is somewhat better than the same rating for MKKGY (100) in the null industry. This means that SUPN’s stock grew somewhat faster than MKKGY’s over the last 12 months.

MKKGY's SMR Rating (70) in the null industry is in the same range as SUPN (81) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's Price Growth Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for MKKGY (78) in the null industry. This means that SUPN’s stock grew somewhat faster than MKKGY’s over the last 12 months.

MKKGY's P/E Growth Rating (89) in the null industry is in the same range as SUPN (100) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew similarly to SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYSUPN
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
68%
Momentum
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 6 days ago
58%
Bullish Trend 4 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 14 days ago
63%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSMVX18.200.17
+0.94%
Jackson Square SMID-Cap Growth Inv
RDLCX10.510.06
+0.57%
Columbia Disciplined Growth C
RIGIX44.530.25
+0.56%
American Funds Intl Gr and Inc R5E
NGDAX32.760.12
+0.37%
Neuberger Berman Large Cap Growth A
LMRNX33.670.12
+0.36%
1919 Socially Responsive Balanced I

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+0.81%
MKGAF - MKKGY
49%
Loosely correlated
+1.28%
AMPH - MKKGY
25%
Poorly correlated
+1.86%
ZTS - MKKGY
25%
Poorly correlated
+1.68%
SUPN - MKKGY
25%
Poorly correlated
-0.32%
INDV - MKKGY
24%
Poorly correlated
+4.87%
More

SUPN and

Correlation & Price change

A.I.dvisor tells us that SUPN and DRRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUPN and DRRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-0.32%
DRRX - SUPN
32%
Poorly correlated
N/A
DVAX - SUPN
29%
Poorly correlated
+0.51%
SNDL - SUPN
27%
Poorly correlated
-5.28%
ACET - SUPN
27%
Poorly correlated
+0.14%
ESPR - SUPN
26%
Poorly correlated
+3.52%
More